Alerts

The combination of products may not be suitable for use as a vehicle transport device.

Otto Bock Australia Pty Ltd has initiated a recall of a number of mobility chairs consisting of the combination of the Otto Bock Discovery Wheelbase and the Leckey Mygo Seat.

Abbott Diabetes Care has identified a problem associated with the slow filling with certain lots of Optium blood glucose test strips.

Updated advisory.

We are recalling Thelin (sitaxentan) worldwide due to serious liver risks. Consult your doctor if you have concerns.

Seasonal flu vaccine: Response to the West Australian (Stokes) Review

Some cartons of Perindopril 2mg tablets labelled with batch numbers 24967, 24979, 25180, 25184 may contain Perindopril 8mg tablets

We have notified Johnson & Johnson Pacific that we are undertaking a consumer level recall of selected lots of 1-Day Acuvue TruEye contact lenses, as a precautionary measure.

Sponsor dispatched recall letters to all affected optometrists

Do not use So Hard for Men tablets, Shaguar tablets, and Pulse8 for Women capsules as they contain undeclared tadalafil and are not approved. Consult your doctor if you have concerns.

Weight loss drug Sibutramine (Reductil) withdrawn in Australia due to heart risks.

About Brachytherapy kits (regulatory status).

The national immunisation program with Panvax® began on 30 September 2009. The TGA has been closely monitoring any side effects from the use of the vaccine.

The TGA is aware that the French authorities have now released an updated statement in regard to the testing of the PIP implants:

The Therapeutic Goods Administration (TGA) has received enquiries about the recall of the LCS® DuofixTM Femoral Knee Replacement Component.

We are analysing the safety of the Panvax H1N1 vaccine following reports of febrile convulsions in children.

We are investigating febrile reactions in young children following the 2010 flu vaccine and have paused its use for kids under 5 in Western Australia.

The Therapeutic Goods Administration (TGA) advises that Octapharma Australia Pty Ltd has agreed to a precautionary voluntary recall of all batches of Octagam intravenous immunoglobulin solutions from the Australian market.

Panvax Junior is being recalled because of a drop in potency, and all available stocks are being removed.

Testing on Australian Poly Implant Prothèse (PIP) samples of implants has been undertaken by TGA

Consumers are advised to stop using Hydroxycut products due to serious adverse reactions, including liver toxicity. We highlight differences between US and Australian formulations and recommend caution. Consult your doctor if concerned.